aRCC: 1L Treatment Options and Patient Management
ASCO GU 2022 Highlights on Adjuvant and Consolidative Therapy in Oligometastatic Renal Cell Carcinoma
By
ASCO Genitourinary Cancers Symposium
FEATURING
Naomi Haas
By
ASCO Genitourinary Cancers Symposium
FEATURING
Naomi Haas
Login to view comments.
Click here to Login
aRCC: 1L Treatment Options and Patient Management